ViiV HEALTHCARE RANKS #1 IN PATIENTVIEW CORPORATE REPUTATION SURVEY
ViiV Healthcare is extremely proud to be the highest-ranked company in the PatientView ‘Corporate Reputation of Pharma – from the Perspective of Patient Groups’ report for the fourth year running, having this year achieved top scores across all seven of the evaluation indicators.
This recognition is testament to ViiV Healthcare’s strong focus and commitment to people living with HIV and the way we work in partnership with patient groups to play our part in responding to the HIV epidemic.
| Company |
Final Rank |
Average score across 7 indicators |
| ViiV Healthcare |
1 |
47.5% |
| AbbVie |
2 | 35.3% |
| Novartis |
3 | 26.0% |
| Novo Nordisk |
4 | 25.4% |
| Gilead Sciences |
5 | 26.1% |
| Grifols |
6 | 24.1% |
| Janssen |
7 | 23.4% |
| Roche |
8 | 22.0% |
| Lundbeck |
9 | 21.7% |
| Shire |
10 | 22.2% |
| UCB |
11 | 20.7% |
Click here to read the full PatientView press release
Media contacts
For our corporate press office, email: Catherine Hartley
OR call +44 7557 290 420
For US-specific media enquiries,email:audrey.x.abernathy@viivhealthcare.com
OR call +1 919 605 4521
